Department of Digestive Surgery and Surgical Oncology, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Department of Neurosurgery, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Int J Oncol. 2014 Nov;45(5):1857-66. doi: 10.3892/ijo.2014.2603. Epub 2014 Aug 14.
Cancer stem cells (CSCs) have been studied for their self-renewal capacity and pluripotency, as well as their resistance to anticancer therapy and their ability to metastasize to distant organs. CSCs are difficult to study because their population is quite low in tumor specimens. To overcome this problem, we established a culture method to induce a pancreatic cancer stem-like cell (P-CSLC)-enriched population from human pancreatic cancer cell lines. Human pancreatic cancer cell lines established at our department were cultured in CSC-inducing media containing epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), leukemia inhibitory factor (LIF), neural cell survivor factor-1 (NSF-1), and N-acetylcysteine. Sphere cells were obtained and then transferred to a laminin-coated dish and cultured for approximately two months. The surface markers, gene expression, aldehyde dehydrogenase (ALDH) activity, cell cycle, and tumorigenicity of these induced cells were examined for their stem cell-like characteristics. The population of these induced cells expanded within a few months. The ratio of CD24high, CD44high, epithelial specific antigen (ESA) high, and CD44variant (CD44v) high cells in the induced cells was greatly enriched. The induced cells stayed in the G0/G1 phase and demonstrated mesenchymal and stemness properties. The induced cells had high tumorigenic potential. Thus, we established a culture method to induce a P-CSLC-enriched population from human pancreatic cancer cell lines. The CSLC population was enriched approximately 100-fold with this method. Our culture method may contribute to the precise analysis of CSCs and thus support the establishment of CSC-targeting therapy.
癌症干细胞(CSCs)因其自我更新能力和多能性,以及对抗癌治疗的耐药性和转移到远处器官的能力而受到研究。CSCs 很难研究,因为它们在肿瘤标本中的数量非常低。为了克服这个问题,我们建立了一种培养方法,从人胰腺癌细胞系中诱导富含胰腺癌症干细胞样细胞(P-CSLC)的群体。我们系建立的人胰腺癌细胞系在含有表皮生长因子(EGF)、碱性成纤维细胞生长因子(bFGF)、白血病抑制因子(LIF)、神经细胞存活因子-1(NSF-1)和 N-乙酰半胱氨酸的 CSC 诱导培养基中培养。获得球体细胞,然后将其转移到层粘连蛋白包被的培养皿中培养约两个月。这些诱导细胞的表面标志物、基因表达、醛脱氢酶(ALDH)活性、细胞周期和致瘤性被检查以确定其干细胞样特征。这些诱导细胞在几个月内迅速扩增。诱导细胞中 CD24high、CD44high、上皮特异性抗原(ESA)high 和 CD44variant(CD44v)high 细胞的比例大大富集。诱导细胞停留在 G0/G1 期,并表现出间充质和干细胞特性。诱导细胞具有高致瘤潜能。因此,我们建立了一种从人胰腺癌细胞系中诱导富含 P-CSLC 的群体的培养方法。用这种方法,CSLC 群体富集了约 100 倍。我们的培养方法可能有助于对 CSCs 的精确分析,从而支持 CSC 靶向治疗的建立。